Sysmex Corporation (TYO:6869)
Japan
· Delayed Price · Currency is JPY 2,774.50
+10.00 (0.36%)
Feb 19, 2025, 3:30 PM JST
Sysmex Revenue
Sysmex had revenue of 124.39B JPY in the quarter ending December 31, 2024, with 9.28% growth. This brings the company's revenue in the last twelve months to 501.85B, up 14.50% year-over-year. In the fiscal year ending March 31, 2024, Sysmex had annual revenue of 461.51B with 12.43% growth.
Revenue (ttm)
501.85B
Revenue Growth
+14.50%
P/S Ratio
3.40
Revenue / Employee
49.98M
Employees
10,042
Market Cap
1,707.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 461.51B | 51.01B | 12.43% |
| Mar 31, 2023 | 410.50B | 46.72B | 12.84% |
| Mar 31, 2022 | 363.78B | 58.71B | 19.24% |
| Mar 31, 2021 | 305.07B | 3.09B | 1.02% |
| Mar 31, 2020 | 301.98B | 8.47B | 2.89% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 837.44B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |
Sysmex News
- 10 days ago - Sysmex reports 9M results - Seeking Alpha
- 3 months ago - Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B - Seeking Alpha